# Stage 5B.2 V4 — Model & Workspace Handoff

## 1. Status Summary

- **Current Stage**: Stage 5B.2 (Multi-Speaker Overlap Optimization & Attribution) — V4 Corrective Audit Complete.
- **Git HEAD**: `1288c1d6e260bf8a575a8e27488fbb03d46022c0` on branch `main`.
- **Working Tree**: Clean across all repository paths. All V4 artifacts are isolated within `research_stages/stage5b/stage5b_2_overlap_optimization/audit_corrections_v4/`.
- **Unit Test Status**: 21 / 21 unit tests passed in 0.011s (direct production imports, zero mocked code).
- **Audit Defect Resolutions**:
  1. *Audit A (Primary Determinism)*: Canonical alphabetical tie-breaking `sorted(spk_counts.items(), key=lambda x: (-x[1], str(x[0])))[0][0]` implemented and verified.
  2. *Audit B (Interval Union)*: Exact 1D interval union implemented in `attribute_secondary_oracle_multilabel`. Forensic scan of RTTMs complete (48.0s inflation in R02 eliminated, 0 attribution changes).
  3. *Audit C (M2 Prototype Purity)*: Added `cache_dir` injection and verified with synthetic fixture tests (192d, 256d, 448d, clean, contaminated, low-purity, empty, permuted).
  4. *Audit D (Full Dispatcher Invariance)*: Dispatcher permutation invariance verified across segments, ground-truth, dictionaries, and ties.

---

## 2. Core Scientific Findings

1. **Integrated Multi-Expert Configuration `O42-R2`**:
   - Delivers targeted benefit on dense conversational overlap (`R04_bwc_traffic_stop`): DER decreases from $21.75\%$ to **$13.66\%$** ($\Delta = -8.09\%$), JER decreases by $-0.54\%$, missed speech decreases by $-8.74\%$.
   - Does not establish a statistically significant corpus-wide DER reduction over baseline `O02`: Macro DER $+0.52\%$ ($24.31\% \to 24.83\%$, $95\%$ CI $[-2.54\%, +3.23\%]$, $p=0.8750$).
2. **Oracle Ceiling Configurations**:
   - `O34-R2` (Predicted Overlap + Hungarian Multi-Label): Macro DER $26.69\%$ (c0) / $22.75\%$ (c25).
   - `O35-R2` (Ground-Truth Overlap + Hungarian Multi-Label): Macro DER $23.36\%$ (c0) / $19.41\%$ (c25).

---

## 3. Explicit Stop Condition

**STOP — AWAITING USER REVIEW AND AUTHORIZATION**

- **Do NOT proceed to Stage 5B.4 (Integration & End-to-End Evaluation).**
- **Do NOT freeze Stage 5B.2 without explicit user authorization.**
- **Await user review and instruction on next steps.**
